论文部分内容阅读
观察双歧杆菌乳杆菌三联活菌片和茵栀黄颗粒辅助治疗新生儿高胆红素血症的疗效。将60例新生儿高胆红素血症随机分为治疗组和对照组各30例。对照组单纯采用常规治疗;治疗组在常规治疗基础上予以双歧杆菌乳杆菌三联活菌片和茵栀黄颗粒口服治疗。比较2组胆红素改善情况治疗组治疗后日均胆红素下降高于对照组(P<0.01),且胆红素降至正常天数少于对照组,差异均有统计学意义(P<0.01)。双歧杆菌乳杆菌三联活菌片和茵栀黄颗粒辅助治疗新生儿高胆红素血症疗效显著,值得推广。
To observe the effect of Lactobacillus bifidum triple viable tablet and Yinzhihuang granule in adjuvant treatment of neonatal hyperbilirubinemia. 60 neonates with hyperbilirubinemia were randomly divided into treatment group and control group, 30 cases each. The control group was treated with routine treatment only. The treatment group was given oral treatment of Lactobacillus bifidum triple active viable tablets and Yinzhihuang granules on the basis of routine treatment. Comparing the two groups to improve the situation of bilirubin in treatment group after treatment, the daily bilirubin decreased more than the control group (P <0.01), and bilirubin decreased to normal days less than the control group, the difference was statistically significant (P < 0.01). Bifidobacterium Lactobacillus triple viable tablets and Yinzhihuang granules adjuvant treatment of neonatal hyperbilirubinemia significant effect, it is worth promoting.